Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRIVE platform trial of S-217622 for hospitalized COVID-19
2022-501020-19-01Phase 3Completed
- Sponsor
- University of Minnesota
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 25
01
Overview
Phase 3, randomised trial of ensitrelvir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University of Minnesota. Primary endpoint: Days to Recovery Scale over 60 days. Started Apr 2023; status: completed.
02
Drugs
ensitrelvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2022-501020-19-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501020-19-01.